Folding and dimerization kinetics of bone morphogenetic protein-2, a member of the transforming growth factor-β family

FEBS Journal

Volumn 280, Issue 1, 2013, Pages 83-92

  Vallejo, Luis F ^a   Rinas, Ursula ^a,b  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

bone morphogenetic protein 2 (BMP 2); cystine knot; kinetics; protein folding and dimerization; TGF family

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; DISULFIDE; GUANIDINE; THIOL;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIMERIZATION; IONIC STRENGTH; MOLECULAR INTERACTION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN REFOLDING; PROTEIN UNFOLDING; REACTION ANALYSIS; STATIC ELECTRICITY; TEMPERATURE MEASUREMENT;

BONE MORPHOGENETIC PROTEIN 2; BUFFERS; GLUTATHIONE DISULFIDE; GUANIDINE; HUMANS; KINETICS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; SODIUM CHLORIDE; TGF-BETA SUPERFAMILY PROTEINS;

EID: 84872022338     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12051     Document Type: Article

References (27)

1. Cancedda R, Giannoni P, &, Mastrogiacomo M, (2007) A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 28, 4240-4250.
2. Bessa PC, Casal M, &, Reis RL, (2008) Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2, 1-13.
3. Bessa PC, Casal M, &, Reis RL, (2008) Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2, 81-96.
4. Lo KW, Ulery BD, Ashe KM, &, Laurencin CT, (2012) Studies of bone morphogenetic protein based surgical repair. Adv Drug Deliv Rev 64, 1277-1291.
5. Isaacs NW, (1995) Cystine knots. Curr Opin Struct Biol 5, 391-395.
6. Griffith DL, Keck PC, Sampath TK, Rueger D, &, Carlson WD, (1996) Three dimensional structure of recombinant human osteogenic protein 1; structural paradigm for the transforming growth factor b superfamily. Proc Natl Acad Sci USA 93, 878-883.
7. McDonald NQ, &, Hendrickson WA, (1993) A structural superfamily of growth factors containing a cystine knot motif. Cell 73, 421-424.
8. Scheufler C, Sebald W, &, Hülsmeyer M, (1999) Crystal structure of human bone morphogenetic protein-2 at 2.7 Å resolution. J Mol Biol 287, 103-115.
9. Ruppert R, Hoffmann E, &, Sebald W, (1996) Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur J Biochem 237, 295-302.
10. Muller YA, Heiring C, Misselwitz R, Welfle K, &, Welfle H, (2002) The cystine knot promotes folding and not thermodynamic stability in vascular endothelial growth factor. J Biol Chem 277, 43410-43416.
11. Bessho K, Kusumoto K, Fujimura K, Konishi Y, Ogawa Y, Tani Y, &, Iizuka T, (1999) Comparison of recombinant and purified human bone morphogenetic protein. Br J Oral Maxillofac Surg 37, 2-5.
12. Wang EA, Rosen V, Cordes P, Hewick RM, Kriz MJ, Luxenberg DP, Sibley BS, &, Wozney JM, (1988) Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA 85, 9484-9488.
13. Sampath TK, &, Reddi AH, (1981) Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci USA 78, 7599-7603.
14. Sato T, Iwata H, Takahashi M, &, Miura T, (1993) Heat tolerance of activity toward ectopic bone formation by rabbit bone matrix protein. Ann Chir Gynaecol Suppl 207, 37-40.
15. von Einem S, Schwarz E, &, Rudolph R, (2010) A novel TWO-STEP renaturation procedure for efficient production of recombinant BMP-2. Protein Expr Purif 73, 65-69.
16. Vallejo LF, &, Rinas U, (2004) Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration. Biotechnol Bioeng 85, 601-609.
17. Vallejo LF, Brokelmann M, Marten S, Trappe S, Cabrera-Crespo J, Hoffmann A, Gross G, Weich HA, &, Rinas U, (2002) Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. J Biotechnol 94, 185-194.
18. Hillger F, Herr G, Rudolph R, &, Schwarz E, (2005) Biophysical comparison of BMP-2, proBMP-2 and the free propeptide reveals stabilization of the pro-peptide by the mature growth factor. J Biol Chem 250, 14974-14980.
19. Vallejo LF, &, Rinas U, (2004) Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins. Microb Cell Fact 3, 11.
20. Philo JS, Rosenfeld R, Arakawa T, Wen J, &, Narhi LO, (1993) Refolding of brain-derived neurotrophic factor from guanidine hydrochloride: kinetic trapping in a collapsed form which is incompetent for dimerization. Biochemistry 32, 10812-10818.
21. Rattenholl A, Lilie H, Grossmann A, Stern A, Schwarz E, &, Rudolph R, (2001) The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies. Eur J Biochem 268, 3296-3303.
22. Rattenholl A, Ruoppolo M, Flagiello A, Monti M, Vinci F, Marino G, Lilie H, Schwarz E, &, Rudolph R, (2001) Pro-sequence assisted folding and disulfide bond formation of human nerve growth factor. J Mol Biol 305, 523-533.
23. Müller C, Richter S, &, Rinas U, (2003) Kinetics control preferential heterodimer formation of platelet-derived growth factor from unfolded A- and B-chains. J Biol Chem 278, 18330-18335.
24. Wu C, Belenda C, Leroux JC, &, Gauthier MA, (2011) Interplay of chemical microenvironment and redox environment on thiol-disulfide exchange kinetics. Chem Eur J 17, 10064-10070.
25. Bulaj G, Kortemme T, &, Goldenberg DP, (1998) Ionization-reactivity relationships for cysteine thiols in polypeptides. Biochemistry 37, 8965-8972.
26. Wetlaufer DB, (1962) Ultraviolet spectra of proteins and amino acids. Adv Prot Chem 17, 303-390.
27. Wendler J, Vallejo LF, Rinas U, &, Bilitewski U, (2005) Application of an SPR-based receptor assay for the determination of biologically active recombinant bone morphogenetic protein-2. Anal Bioanal Chem 381, 1056-1064.